Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Increasing the time of exposure to aerosol measles vaccine elicits an immune response equivalent to that seen in 9-month-old Mexican children given the same dose subcutaneously.

Wong-Chew RM, García-León ML, Espinosa-Torres Torrija B, Hernández-Pérez B, Cardiel-Marmolejo LE, Beeler JA, Audet S, Santos-Preciado JI.

J Infect Dis. 2011 Aug 1;204(3):426-32. doi: 10.1093/infdis/jir278.

2.

Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.

Wong-Chew RM, Islas-Romero R, García-García Mde L, Beeler JA, Audet S, Santos-Preciado JI, Gans H, Lew-Yasukawa L, Maldonado YA, Arvin AM, Valdespino-Gómez JL.

Vaccine. 2006 Jan 30;24(5):683-90. Epub 2005 Aug 24.

PMID:
16154241
3.

Induction of cellular and humoral immunity after aerosol or subcutaneous administration of Edmonston-Zagreb measles vaccine as a primary dose to 12-month-old children.

Wong-Chew RM, Islas-Romero R, García-García Mde L, Beeler JA, Audet S, Santos-Preciado JI, Gans H, Lew-Yasukawa L, Maldonado YA, Arvin AM, Valdespino-Gómez JL.

J Infect Dis. 2004 Jan 15;189(2):254-7. Epub 2004 Jan 5.

PMID:
14722890
4.

Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial.

Dilraj A, Cutts FT, de Castro JF, Wheeler JG, Brown D, Roth C, Coovadia HM, Bennett JV.

Lancet. 2000 Mar 4;355(9206):798-803.

PMID:
10711928
5.

Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.

Dilraj A, Sukhoo R, Cutts FT, Bennett JV.

Vaccine. 2007 May 22;25(21):4170-4. Epub 2007 Mar 20.

PMID:
17408818
6.

Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.

Gans HA, Yasukawa LL, Alderson A, Rinki M, DeHovitz R, Beeler J, Audet S, Maldonado Y, Arvin AM.

J Infect Dis. 2004 Jul 1;190(1):83-90. Epub 2004 May 26.

PMID:
15195246
7.

A correlation of measles specific antibodies and the number of plasmacytoid dendritic cells is observed after measles vaccination in 9 month old infants.

García-León ML, Bonifaz LC, Espinosa-Torres B, Hernández-Pérez B, Cardiel-Marmolejo L, Santos-Preciado JI, Wong-Chew RM.

Hum Vaccin Immunother. 2015;11(7):1762-9. doi: 10.1080/21645515.2015.1032488.

8.

Measles humoral and cell-mediated immunity in children aged 5-10 years after primary measles immunization administered at 6 or 9 months of age.

Gans HA, Yasukawa LL, Sung P, Sullivan B, DeHovitz R, Audet S, Beeler J, Arvin AM.

J Infect Dis. 2013 Feb 15;207(4):574-82. doi: 10.1093/infdis/jis719. Epub 2013 Jan 8.

9.

Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine.

Whittle HC, Rowland MG, Mann GF, Lamb WH, Lewis RA.

Lancet. 1984 Oct 13;2(8407):834-7.

PMID:
6148572
10.

Cell-mediated and antibody immune responses to AIK-C and Connaught monovalent measles vaccine given to 6 month old infants.

Pabst HF, Spady DW, Carson MM, Krezolek MP, Barreto L, Wittes RC.

Vaccine. 1999 Apr 9;17(15-16):1910-8.

PMID:
10217589
11.

Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren.

Bennett JV, Fernandez de Castro J, Valdespino-Gomez JL, Garcia-Garcia Mde L, Islas-Romero R, Echaniz-Aviles G, Jimenez-Corona A, Sepulveda-Amor J.

Bull World Health Organ. 2002;80(10):806-12. Epub 2002 Nov 28.

12.

Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months.

Gans HA, Arvin AM, Galinus J, Logan L, DeHovitz R, Maldonado Y.

JAMA. 1998 Aug 12;280(6):527-32.

PMID:
9707142
13.

Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life.

Gans H, DeHovitz R, Forghani B, Beeler J, Maldonado Y, Arvin AM.

Vaccine. 2003 Jul 28;21(24):3398-405. Review.

PMID:
12850348
14.
15.

A randomized, controlled trial of an aerosolized vaccine against measles.

Low N, Bavdekar A, Jeyaseelan L, Hirve S, Ramanathan K, Andrews NJ, Shaikh N, Jadi RS, Rajagopal A, Brown KE, Brown D, Fink JB, John O, Scott P, Riveros-Balta AX, Greco M, Dhere R, Kulkarni PS, Henao Restrepo AM.

N Engl J Med. 2015 Apr 16;372(16):1519-29. doi: 10.1056/NEJMoa1407417.

16.

Measles vaccine immunogenicity and antibody persistence in 12 vs 15-month old infants.

Johnson CE, Darbari A, Darbari DS, Nalin D, Whitwell J, Chui LW, Cleves MA, Kumar ML.

Vaccine. 2000 May 8;18(22):2411-5.

PMID:
10738098
17.

A randomized trial demonstrating successful boosting responses following simultaneous aerosols of measles and rubella (MR) vaccines in school age children.

Sepúlveda-Amor J, Valdespino-Gómez JL, García-García Mde L, Bennett J, Islas-Romero R, Echaniz-Aviles G, de Castro JF.

Vaccine. 2002 Jun 21;20(21-22):2790-5.

PMID:
12034106
18.

Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.

Johnson CE, Nalin DR, Chui LW, Whitwell J, Marusyk RG, Kumar ML.

Pediatrics. 1994 Jun;93(6 Pt 1):939-44.

PMID:
8190581
19.

Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months.

Gans H, Yasukawa L, Rinki M, DeHovitz R, Forghani B, Beeler J, Audet S, Maldonado Y, Arvin AM.

J Infect Dis. 2001 Oct 1;184(7):817-26. Epub 2001 Aug 22.

PMID:
11528592
20.

Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines.

Markowitz LE, Sepulveda J, Diaz-Ortega JL, Valdespino JL, Albrecht P, Zell ER, Stewart J, Zarate ML, Bernier RH.

N Engl J Med. 1990 Mar 1;322(9):580-7. Erratum in: N Engl J Med 1990 Mar 22;322(12):863.

Supplemental Content

Support Center